`Petitioners’ Updated Exhibit List
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`DR. REDDY’S LABORATORIES INC, and
`DR. REDDY’S LABORATORIES LTD.,
`Petitioners,
`
`
`
`
`
`
`
`
`
`
`
`v.
`
`MERCK SHARP & DOHME CORP.,
`Patent Owner.
`
`
`
`Case IPR2020-01060
`U.S. Patent No. 7,326,708
`
`
`
`PETITIONERS’ UPDATED EXHIBIT LIST
`
`
`
`IPR2020-01060 (U.S. Patent No. 7,326,708)
`Petitioners’ Updated Exhibit List
`
`
`
`Description
`U.S. Patent No. 7,326,708
`Declaration of Dr. Mukund Chorghade
`CV of Dr. Mukund Chorghade
`WO 03/004498 to Edmonson
`Brittain, Polymorphism in Pharmaceutical Solids
`Bastin et al., Salt Selection and Optimisation [sic] Procedures
`for Pharmaceutical New Chemical Entities
`U.S. Patent No 6,699,871
`Orange Book Entry for Janumet®
`Orange Book Entry for Januvia®
`Complete copy of the prosecution history of the ’708 Patent
`as available for download from the USPTO website
`U.S. Patent No. 4,572,909
`U.S. Provisional Application No. 60/303,474, filed July 6, 2001
`Prescribing Information for Janumet®
`Prescribing Information for Januvia®
`Merck Sharpe & Dohme’s Responses and Objections to
`Defendants’ First Set of Joint Interrogatories (1-10)
`Brown et al., Chemistry: The Central Science (8th rev. ed
`615-618 (2002)
`Declaration of Joseph M. Fortunak, Ph.D.
`CV of Joseph M. Fortunak, Ph.D.
`Email from Merck to Joinder Petitioners Regarding Silent
`Understudy Conditions
`Complaint, Merck Sharp & Dohme Corp. v. Dr. Reddy’s
`Laboratories, Inc. et al., No. 1:20-cv-00847-RGA, ECF 1 (D.
`Del. June 24, 2020)
`Decision, State of Israel Commissioner of Patents, Designs and
`Trademarks, Teva Pharmaceutical Industries Ltd. Opposition to
`Merck Sharp & Dohme Corp. Patent Application No. 172563
`(July 30, 2019)
`Third Declaration of Leonard J. Chyall, Ph.D
`
`Pet’r Ex. #
`1001
`1002
`1003
`1004
`1005
`1006
`
`1007
`1008
`1009
`1010
`
`1011
`1012
`1013
`1014
`1015
`
`1016
`
`1017
`1018
`1019
`
`1020
`
`1021
`
`1022
`
`
`
`
`
`IPR2020-01060 (U.S. Patent No. 7,326,708)
`Petitioners’ Updated Exhibit List
`
`
`Dated: July 30, 2020
`
`
`
`
`
`
`
`Respectfully submitted
`By:
`/ Russell W. Faegenburg /
`Russell W. Faegenburg
`Reg. No. 77,876
`
`Lead Counsel for Petitioners Dr. Reddy’s
`Laboratories, Inc. and Dr. Reddy’s
`Laboratories, Ltd.
`
`
`
`
`
`
`
`
`
`CERTIFICATION OF SERVICE ON PATENT OWNER
`
`Pursuant to 37 C.F.R. §§ 42.6(e) and 42.8(b)(4), the undersigned hereby
`certifies that the above-captioned “PETITIONERS’ UPDATED EXHIBIT LIST”
`was served electronically via e-mail on July 30, 2020 on the following counsel of
`record::
`
`Stanley E. Fisher
` Bruce R. Genderson
`Jessamyn S. Berniker
`Alexander S. Zolan
`Elise M. Baumgarten
`Shaun P. Mahaffy
`Anthony H. Sheh
`WILLIAMS & CONNOLLY LLP
`725 Twelfth Street, N.W.
`Washington, DC 20005
`T: (202) 434-5000
`F: (202) 434-5029
`sfisher@wc.com
`bgenderson@wc.com
`jberniker@wc.com
`azolan@wc.com
`ebaumgarten@wc.com
`smahaffy@wc.com
`asheh@wc.com
`MerckSitagliptin@wc.com
`
`
`
`Dated: July 30, 2020
`
`
`
`
`
`
`
`Respectfully submitted
`By:
`/ Russell W. Faegenburg /
`Russell W. Faegenburg
`Reg. No. 77,876
`
`Lead Counsel for Petitioners Dr. Reddy’s
`Laboratories, Inc. and Dr. Reddy’s
`Laboratories, Ltd.
`
`
`
`